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Summary
In the last 25 years, several non-invasive techniques based on
the attenuation of ionising radiation have been developed to
quantify bone mineral density in the axial and peripheral
skeleton. They represent valid methods for determination of
BMD and explain about 60-80% of the variation in bone
strength. However, they provide only limited information on
bone structure and on bone material properties. Quantitative
ultrasound (QUS) methods have been introduced for the as-
sessment of skeletal status in osteoporosis; the physical in-
teraction of ultrasound and bone is complex, and not com-
pletely understood; however, it is considered that QUS pro-
vides information both on bone mass and structure. QUS, be-
cause of the lack of ionising radiation, relative portability of
the equipment, ease of use, and low cost, has seen marked
success around the world, though it has been approved only
in 1999 by FDA for clinical use in USA. The relative contribu-
tion to bone assessment of both ultrasound and the current
gold standard method for bone assessment, dual x-ray ab-
sorptiometry (DXA), is still to be determined; nevertheless,
QUS has demonstrated that it is able to detect bone fragility
as well as DXA. Further studies needed on the diagnosis of
osteoporosis using ultrasound, because current diagnostic
threshold designed by the World Health Organization, cannot
be always applied to QUS parameters. A better option for QUS
would be to report results in terms of fracture risk, keeping in
mind that a risk estimate depends not only on QUS or DXA
measurement, but also on clinical risk factors. 
KEY WORDS: quantitative ultrasound, bone quality, speed of sound, broad-
band ultrasound attenuation.
Introduction
The measurement of bone density has became an established
method to determine the skeletal status for diagnosis and treat-
ment of osteoporosis. Diagnosis of osteoporosis today is
based mainly on this measurement since bone density at vari-
ous anatomic sites has been found to be strongly associated
with future fractures. However, both epidemiological and inter-
ventional investigations have identified risk factors for fracture
other than bone mass. In particular it has been demonstrated
that bone structure may play an important role in the determi-
nation of fracture. Therefore the ideal diagnostic device should
be able to measure bone fragility, whatever the cause is, and
not just any decrease in bone mass. QUS seems to provide in-
formation that is partly independent from bone density and is
able to predict osteoporotic fractures. QUS offer the advantage
of small size, relatively quick and simple measurements, no
need of ionising radiation and low cost. For these characteris-
tics, QUS has continued to be of interest in the last two
decades; in 1999, the United States Food and Drug Adminis-
tration approved five different ultrasound instruments for the
routine diagnosis of osteoporosis, determination of fracture risk
and monitoring bone changes. 
Ultrasound parameters
Ultrasound is a mechanical wave vibrating at a frequency
range from 20,000 waves/s to 100,000 waves/s. The ability of
most physical methods of diagnosis (quantitative ultrasound of
bone in this case) to provide information on the properties of a
particular medium depends on the way in which the ultrasound
wave is modified by the medium. With ultrasonic propagation
through bone, both the velocity of transmission and the ampli-
tude are affected by the medium. Bone tissue therefore may be
characterized in terms of ultrasound velocity and ultrasound at-
tenuation. From this simple, fundamental starting point, it is in-
teresting to note the variety of approach taken in implementing
clinical measurements of velocity and attenuation in commer-
cial quantitative ultrasound devices. In fact, commercial bone
QUS has utilized transit time velocity measurement (the time
for the arrival of ultrasound signal at the receiving transducer),
with different definition: bone velocity (BV), heel velocity (HV),
speed of sound (SOS). For attenuation, more uniformity is pre-
sent among commercial devices; in fact attenuation is typically
characterized by broadband ultrasound attenuation (BUA), the
slope at which attenuation increases with frequencies, general-
ly between 0.2 MHz and 0.6 MHz. The velocity of ultrasound
wave propagation is determined by the transit time and by the
width crossed, and it is expressed as m/s. Speed of sound
(SOS) can be related to the mechanical properties by the
equation: SOS = (E/r)1/2, where E is the modulus of elasticity
and r is the bone density expressed in gr/cm3. Current com-
mercial systems for studying the calcaneus use two transduc-
ers (a transmitter and a receiver), positioned on each side of
the bone to be measured, and three different methods of calcu-
lating velocity have been employed: heel velocity (calcaneus +
soft tissue), bone velocity (calcaneus only) and time of flight
velocity (TOF) (between transducers positioned at a fixed dis-
tance and assuming a constant heel thickness). These three
approaches to velocity derivation yield slightly different values,
but correlate strongly with each other (1). As an ultrasound
wave propagates through the bone some of its energy is lost,
and this phenomenon is known as attenuation. Factors con-
tributing to the attenuation in bone include scattering, diffrac-
tion and absorption. Absorption predominates in cortical bone
and scattering in trabecular bone. The increase in attenuation
as a function of the frequency is measured by comparing the
amplitude spectrum for a reference material with that of the
measured sample. The slope of attenuation (BUA) in dB/MHz
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is given by linear regression of the spectral amplitude differ-
ence. Some manufacturers have implemented derived para-
meters from BUA and velocity, such as Stiffness, Quantitative
Ultrasound Index (QUI), soundness and osteo sono-assess-
ment index (OSI). The combination of BUA and SOS into a sin-
gle parameter has been shown to improve precision; further-
more, from the point of view of clinical interpretation, a single
parameter, which combines velocity and attenuation, can sim-
plify interpretation. 
QUS and bone
Velocity and BUA provide quantitative information on ultra-
sound interaction with the medium; it is currently accepted that
QUS parameters are not only influenced by bone density, but
also by bone structure. Theory suggests that BUA is deter-
mined by bone density and bone microarchitecture, while SOS
is influenced by the elasticity of bone as well as by bone densi-
ty. However, the exact mechanisms of ultrasound interaction
with bone and the physical properties measured remain unde-
termined. Considerable data exist showing the positive depen-
dence of attenuation and velocity on bone mineral density (2).
The relationship between QUS and BMD are higher in vitro
than in vivo, probably also as a consequence of the presence
of soft tissue and of anatomic discordance (3); otherwise this
poor association with QUS and BMD has been often attributed
to the fact that QUS may measure structure. In particular it has
been shown that BUA depends on the trabecular orientation (4,
5); moreover, Gluer et al. (4) have suggested that SOS is relat-
ed to trabecular separation and BUA either to trabecular sepa-
ration or connectivity. Other Authors did not find any relation-
ship between histomorphometry and QUS parameters after
correction for BMD (6). Nicholson et al. (7) have shown that the
ability of QUS to reflect bone structure is also dependent on
the direction of the measurement. Recently it has been demon-
strated, in human calcaneal specimens, that QUS reflects es-
pecially BMD and to a less extent, bone microarchitecture (8).
It has been also shown that SOS, after correction for BMD, is
the best predictor of Young modulus, indicating that this para-
meter can give information on the mechanical architecture of
trabecolar bone (9). In cadaver studies, calcaneal ultrasound
correlates with femoral and vertebral strength, but the predic-
tive ability is less than, and it is not independent, from BMD
measurements (10-11). However, in contrast to these results,
Lochmuller et al. (12) found that calcaneal QUS correlates with
failure load of the proximal femur similarly to femoral neck
BMD. 
In conclusion, qualitative evidence for the influence of structure
on ultrasound exists, but there are no conclusive data demon-
strating that ultrasound provides useful information on specific
structural parameter at clinical sites. 
Calcaneal QUS devices
Since the pioneering work of Langton et al. in 1984 (13), many
clinical quantitative ultrasound machines have been developed
and there are currently a multitude of different devices on the
market. Ultrasound transducers are coupled to the subject ei-
ther with water (wet systems) or gel (dry systems). The sites
measured also vary, but most of the available devices measure
the calcaneus. The calcaneus is the most studied skeletal site
for QUS assessment for several reasons; the high percentage
of trabecolar bone (90%), which has a turnover higher than
cortical bone, allows early evidence of metabolic changes; the
calcaneus is also easily accessible and the mediolateral sur-
faces are fairly flat and parallel, thus reducing repositioning er-
ror. The choice of the calcaneus as a test site has been sup-
ported by Black et al. (14), who reported that the calcaneus ap-
peared to be the optimal bone mineral density measurement
site in the prediction of any type of osteoporotic fracture in peri-
menopausal women. In Table I are reported commercial cal-
caneal QUS devices. Although the Walker Sonix UBA 575 is
no longer available, it is listed because it provides a back-
ground for current systems and also because many studies
were carried out using this system. These devices show great
technological diversity: coupling, mode of data acquisition, vari-
ables, calibration method, hardware performance, analysis al-
gorithms, transducer designs. These differences, combined
with the fact that no absolute standard exists for ultrasound
measurements, cause the impossibility to directly translate the
clinical utility of a validated system into that of other technologi-
cally different QUS devices. Among water bath systems, the
Achilles plus, available in the early 1990s, for its proved ability
to predict fragility fractures and comparability to central DXA, is
one of the most used ultrasound devices. Compared with wa-
ter-coupled systems, gel-coupled systems, such as Sahara,
have the advantage of being more portable and having fewer
potential concerns about hygiene, disadvantage results from
their reduced control over the measurement environment, such
as the stability of the temperature and hydration of the tested
heel. These factors could significantly influence the precision of
the measurements. GE Lunar has recently released a new ver-
sion of Achilles called Achilles Insight: this is an imaging ultra-
sonometer, based on the Achilles plus, but water is contained
in an inflatable silicone pad and isopropyl alcohol spray is used
to provide the coupling (Fig. 1). A good agreement between
Achilles plus and Achilles Insight has been recently demon-
strated (15). Regarding the precision, for the same variables,
there is moderate difference among different devices; in Table
I are reported the values of short-term precision usually report-
ed for each device from many studies (Table I). For QUS mea-
surements at calcaneus sources of low precision include pres-
ence of soft tissue, thickness variation, coupling agent charac-
teristics, repositioning error, duration of immersion of the foot
and temperature (16-18). Foot positioning is considered the
primary source of error in BUA measurement because of the
lack of homogeneity of the calcaneus (18). 
Clinical application of QUS
Although considerable effort has been made to characterize
the relationship between QUS and BMD measurement of the
same skeletal site, from a clinical point of view, the most impor-
tant issue regarding QUS is its ability to predict fracture risk.
There is ample evidence documenting the ability of calcaneal
QUS to predict osteoporotic fracture risk both in women (19-
34) and in men (31, 34). It is important to emphasize that QUS
parameters result independent predictors of osteoporotic frac-
ture, even after adjustment for BMD (19-24, 30). These studies
reported a strong association of calcaneal QUS with vertebral
fracture (19, 20, 24, 27, 32) hip fracture (21-23, 28, 33) and os-
teoporotic fractures in general (30, 31, 34). Logistic regression
analysis has shown that the fracture risk usually increases by
1.5-2.5 times for every 1 standard deviation reduction of each
QUS parameters. Moreover it has been demonstrated that the
fracture risk prediction increases with both the combination of
QUS and DXA (22, 24, 32). 
Correlation between QUS parameters and BMD, as measured
by X-ray absorptiometry have been under investigation since
QUS was first introduced for clinical practice. Correlation coeffi-
cients usually range from 0.3 to 0.8 and there is general agree-
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ment that QUS and BMD interact differently with bone and that
explains why the correlation between the two methods, even-
though significant, is modest (35, 36). Since WHO has defined
Osteoporosis on the basis of BMD, a sure diagnosis can be
formulated only with a technique that directly measures bone
mineral density, as bone densitometry. However, the useful-
ness of QUS is justified in numerous studies; in fact some Au-
thors have demonstrated that QUS parameters are more pre-
dictive of bone mass than the factor risk evaluation (37, 38). In
other wards, postmenopausal women who should be referred
for further examination by DXA, could be selected better on the
basis of QUS measurement than with risk factors evaluation
alone. Moreover, published data on the cost-effectiveness of
this approach are not sufficient to recommend a population
screening with QUS (37, 39, 40). Moreover, guidelines on the
position of QUS in the diagnosis and therapeutic decision are
not available. In this respect, a crucial point is the evaluation of
the possibility of using WHO criteria also for QUS, since it has
been shown that QUS and DXA cannot always identify the
same population (41). Some studies have shown that the cut-
off of -2.5, utilised for the definition of osteoporosis with DXA,
can be employed also for some QUS devices, such as the
Achilles (42). On the other hand, for other instruments, differ-
ent cut-offs have been calculated (42, 43). Moreover, it has
been recently demonstrated that clinical risk factors are related
both to QUS and DXA parameters when expressed in terms of
Z-score, and that the proportion of postmenopausal women
classified as osteopenic or osteoporotic is similar, with both
DXA and QUS (44). At present no universal cut offs are dis-
posable for QUS parameters and, therefore, even though good
correlations have been showed between parameters obtained
by different devices (45), it is not possible to standardize nor-
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Table I - Calcaneal QUS devices.
Device Manufacture Trasmission Parameter Precision
(cv) (%)
BUA 0.8-4
Achilles plus GE Lunar Water SOS 0.2-0.5
Stiffness 1-2.7
BUA Not available
Achilles Express GE Lunar Water and gel SOS Not available
Stiffness 1-2
BUA 1.4-3.1
Achilles Insight GE Lunar Water and alcohol SOS 0.2-0.4
Stiffness 1.9-2.1
CUBA McCue Gel BUA 1.5-4.5SOS 0.2-0.6
DTU-one Osteometer Water BUA 0.8-2.5SOS 0.2-0.4
Paris Nordland Gel BUA 1.8SOS 0.3
QUS-2 Metra Gel BUA 0.8-2.0
BUA 0.8-5.0
Sahara Hologic Gel SOS 0.2-0.4
QUI 1-3.5
UBIS 5000 DMS Water BUA 0.8-2.5SOS 0.2-0.4
UBA575+ Walker Sonix Water BUA 2-5SOS 0.2-0.6
Figure 1 - Achilles Insight device (GE, Lunar).













mal range as it has been made for DXA. Moreover, QUS refer-
ence phantoms for cross-calibration procedures and standard-
ization methods between different devices are not available.
However, QUS parameters could be considered as an impor-
tant risk factor, allowing to classify a subject as at “low”, “medi-
um” or “high” risk on the basis of QUS result. Ayers et al. have
demonstrated that the associate evaluation of clinical risk fac-
tors and QUS shows a sensitivity in the diagnosis of osteo-
porosis similar or superior to the axial DXA (46); following this
strategy a further DXA evaluation could be indicated only in pa-
tients with positive risk factors and normal QUS (47). A strate-
gy combining QUS, DXA and clinical factors for the identifica-
tion of women needing an appropriate treatment has been re-
cently proposed by Hans et al. (42).
Because of the limited experience, monitoring skeletal changes
solely by QUS cannot be recommended yet (35). The ability of
QUS to monitor change widely depends on the reproducibility
of QUS parameters and on the magnitude of the response.
The time period to follow individual subjects would most likely
exceed those required for bone densitometry; in fact, even
though some studies showed a significant increase of QUS pa-
rameters in patients treated with antiresorptive drugs (48-50), it
is not possible to identify, with QUS, change of bone status in-
duced by these drugs, earlier than 2 years. Nevertheless, for
the possible usefulness of QUS in the follow up, in order to
maximize its ability to monitor change and to minimize any
measurement error, adequate measurement protocols and
quality assurance procedures are needed.
The use of calcaneal QUS has also been proposed in sec-
ondary osteoporosis, such as osteoporosis induced by corti-
costeroids (51, 52) or associated with rheumatoid arthritis (53).
In a recent study, the influence of corticosteroid therapy on
QUS parameters during the first year after renal transplantation
has been investigated (54). The ability of QUS to give us infor-
mation on both bone mass and qualitative characteristics of
bone could be utilized also in the diagnosis of different meta-
bolic bone diseases, such as primary and secondary hyper-
parathyroidism (55, 56). QUS at calcaneus has been employed
also in patients with osteogenesis imperfecta (57) or with
Sudeck’s disease of bone (58). 
Conclusions and future perspectives
A substantial body of knowledge regarding the performance of
QUS techniques has been gathered. To date, evidence sup-
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Table II -  Calcaneal QUS and fracture.
Author Fracture outcome Subjects Velocity BUA Derived parameters
(RR) (RR) (RR)
Selected retrospective studies
Ross,1995 Vertebral 702 women – 1.5-1.7 –
Gonnelli, 1995 Vertebral 304 women 4.5 3.1 4.8 (Stiffness)
Schott, 1995 Hip 129 women 2.7 3.7 3.5 (Stiffness)
Thompson, 1998 All fractures 3180 women 1.5 1.4 1.5 (Stiffness)
Hartl, 2002 Vertebral 500 women 3.0 (Stiffness)
3.8 (QUI)
Ekman, 2002 Hip 99 men 1.9 1.9 2.2 (Stiffness)
Krieg, 2003 Hip 7562 women 2.5 2.3 2.7 (Stiffness)
2.1 2.4 2.4 (QUI)
Forearm 1.6 1.5 1.6 (Stiffness)
1.7 1.7 1.7 (QUI)
Other fractures 1.1 1.1 1.1 (Stiffness)
1.1 1.1 1.2 (QUI)
Gluer, 2004 Vertebral 2837 women 1.4-1.5 1.2-1.4 1.5 (Stiffness)
Gonnelli, 2004 All fractures 401 men 3.0 2.8 3.2 (Stiffness)
Prospective studies
Hans, 1996 Hip 5662 women 1.9 2.0 –
Bauer, 1997 Hip 6189 women 2.0
Non spine 1.3
Pluijm, 1999 Hip 132 men and 1.6 2.3
Non spine 578 women 1.3 1.6
Stewart, 2003 Forearm 1000 women 3.25
All fractures 1.39
Huopio, 2004 All fractures 422 women 1.8 1.7 1.4
Hans, 2004 Hip 5898 women 1.8-2.4 1.9-2.6 1.9-2.8 (Stiffness)
Khaw, 2004 Hip 14824 men and 2.22 1.99
Non hip women 1.96 1.59













ports the use of QUS for the assessment of fracture risk. Addi-
tional clinical applications of QUS, as the assessment of rates
of changes for monitoring disease progression or response to
treatment, require further investigation. Moreover, QUS tech-
nology has tremendous potential for further improvement and
refinement. If one takes an optimistic view, it may eventually be
possible to develop a truly non invasive method that will allow
the investigation of relevant characteristics of skeletal status
that can only be studied by invasive histomorphometric meth-
ods today. QUS may also improve the evaluation of skeletal
properties on a micro level and open new frontiers for more in-
depth and more comprehensive investigation of bone metabo-
lism, including the effect of therapeutic interventions. Currently,
the low cost of the devices makes them very attractive and this
has led to their rapid dissemination in many countries. In the
future, the potential for developments beyond bone densitome-
try may represent an additional promoting factor. QUS will
probably play a dominant role in the assessment of osteoporo-
sis and potentially other skeletal disorders as well.  
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